Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension
NCT03870880
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
215
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
Risperidone ISM 75 mg
DRUG:
Risperidone ISM 100 mg
Sponsor
Rovi Pharmaceuticals Laboratories